A Phase 2 Study of Doripenem In The Treatment of Nosocomial and Ventilator-Associated Pneumonia In Hospitals
Phase of Trial: Phase II
Latest Information Update: 24 Sep 2013
At a glance
- Drugs Doripenem (Primary)
- Indications Bacterial infections; Nosocomial pneumonia
- Focus Therapeutic Use
- Sponsors PriCara
- 04 Jul 2012 Additional lead trial centre identified as reported by EudraCT.
- 04 Jul 2012 Planned number of patients changed from 200 to 1000 as reported by EudraCT.
- 04 Jul 2012 Additional trial location (France) identified as reported by EudraCT.